Literature DB >> 35074181

Outcomes and experience of anatomical partial lobectomy.

Bin Qiu1, Ying Ji1, Fan Zhang1, Guangyu Bai1, Qi Xue1, Mateusz Polaczek2, Davide Tosi3, Terumoto Koike4, Shugeng Gao5, Jie He1.   

Abstract

OBJECTIVE: The use of limited anatomic resection for early-stage lung cancer is widely practiced worldwide. However, most studies have focused on standard segmentectomy or subsegmentectomy, and data on the short-term outcomes after anatomic sublobar resection in China are lacking.
METHODS: In 2014, the use of anatomic partial lobectomy (APL), which is defined as lesion-centered resection of anatomical sublobular parts, was proposed by the National Cancer Center in China. We retrospectively evaluated all consecutive patients who underwent APL between November 2013 and October 2019 from our database, and the operative techniques and short-term outcomes were analyzed.
RESULTS: A total of 3336 patients with a median age of 56 years underwent APL during the study period. Benign lesions were present in 8.5% of all patients and decreased across time. The mean total operation time was 127.3 minutes, the mean overall number of nodal sampling/dissections was 13, and the mean number of stations sampled was 4. Postoperative complications (grade ≥2) developed in 359 patients (10.8%), and no mortality occurred in the 30 days after surgery. Multivariate analysis showed that smoking, surgeon's early experience, thoracotomy or unplanned conversion to thoracotomy, and complex cases were risk factors for the occurrence of postoperative complications.
CONCLUSIONS: Despite the increasing proportion of complex cases treated with APL, the incidence of postoperative complications decreased as our center accumulated surgical experience. APL procedures are safe and feasible when conducted in a specialized center.
Copyright © 2021 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lung cancer; segmentectomy; sublobar resection; surgery

Mesh:

Year:  2021        PMID: 35074181     DOI: 10.1016/j.jtcvs.2021.11.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   6.439


  2 in total

1.  Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.

Authors:  Shengteng Shao; Guisong Song; Yuanyong Wang; Tengfei Yi; Shuo Li; Fuhui Chen; Yang Li; Xiaotong Liu; Bin Han; Yuhong Liu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

2.  Limited-anatomic resection for ground-glass like lung cancer-simplicity does not mean inefficacy.

Authors:  Qiuyuan Li; Kaiqi Jin; Jie Dai; Yang Yang; Gening Jiang
Journal:  Transl Lung Cancer Res       Date:  2022-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.